Morphine aerosols in the palliative care of lung cancer;Dyspnée et aérosols de morphine dans les soins palliatifs du cancer broncho-pulmonaire

Revue des Maladies Respiratoires

Volumn 21, Issue 6 I, 2004, Pages 1091-1097

  Grimbert, D ^a,b   Lubin, O ^a   De Monte, M ^b   Vecellio None, L ^b   Perrier, M ^a   Carre P ^a   Lemarie E ^a,b   Boissinot, E ^a,b   Diot, P ^a,b  

^a CHU BRETONNEAU   (France)

^b INSERM   (France)

Author keywords

Aerosols; Dyspnoea; Lung cancer; Morphine; Palliative care

Indexed keywords

MORPHINE SULFATE;

ADULT; AEROSOL; AGED; ARTICLE; BREATHING RATE; CANCER PALLIATIVE THERAPY; CAPILLARY BLOOD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPNEA; HUMAN; HUMIDIFIER; LUNG CANCER; NEBULIZATION; OXYGEN SATURATION; RANDOMIZED CONTROLLED TRIAL; TERMINAL CARE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 13844310489     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(04)71583-1     Document Type: Article

References (22)

1. Meek PM, Schwartzstein RM, Adams L, Dyspnea: Mechanisms, assessment, and management. A consensus statement. Am J Respir Crit Care Med 1999; 159: 321-40.
2. Cowcher K, Hansk GW: Long term management of respiratory symptoms in advanced cancer. J Pain Symptom Manage 1990; 8: 320-30.
3. Chandler S: Nebulized opioids to treat dyspnoea. Am J Hosp Palliat Care 1999; 16: 418-22.
4. Marin I: Traitement de la dyspnée en fin de vie. Rev Mal Respir 2004; 21: 465-72.
5. Farcombe M, Chater S, Gillin A: Thease of nebulized opioids for breathlessness: a chart review. Palliat Med 1994; 306-12.
6. Farcombe M, Chater S: Clinical application of nebulized opioids for treatment of dyspnoea in patients with malignant disease. Support Care Cancer 1994; 2: 184-7.
7. Farcombe M, Chater S: Case studies outlining use of nebulized morphine for patients with End-Stage chronic lung and cardiac disease. J Pain Symptom Manage 1993; 8: 221-5.
8. Zeppetella G: Nebulized morphine in the palliation of dyspnoea. Palliat Med 1997; 11: 267-75.
9. Noseda A, Carpiaux JP, Markstein C, Meyvaert A, de Maertelaer V: Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine. Eur Respir J 1997; 10: 1079-83.
10. Masood AM, Reed JW, Thomas SHL: Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. Thorax 1995; 50: 629-34.
11. Woodcock AA, Gross ER, Gellert A, Shah S, Johnson M, Geddes DM: Effect of dihydrocodeine, alcohol and caffeine on breathlessness and exercise tolerance in patients with chronic obstruction lung disease and normal blood gases. N Engl J Med 1981; 305: 1611-6.
12. Belvisi MG, Chung K, Jackson DM, Barnes PJ: Opiod modulation of non cholinergic neural broncho-constriction in guinea pig in vivo. Br J Pharmacol 1988; 95: 413-8.
13. Macleod RD, King BJ: Relieving breathlessness with nebulized morphine. Palliat Med 1995; 9: 169.
14. Ward ME, Woodhouse A, Mather LE, Farr SJ, Okikawa JK, Lloyd P, Schuster JA, Rubsamen RM: Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system. Clin Pharmacol Ther 1997; 62: 596-609.
15. Lang E, Jedeykin R: Acute respiratory depression as a complication of nebulized morphine. Can J Anaesth 1998; 45: 60-2.
16. Mancini I, Body JJ: Assessment of dyspnea in advanced cancer patients. Support Care Cancer 1999; 7: 229-32.
17. Lebart L, Morineau A, Warwick KM: Multivariate descriptive statistical analysis. Wiley & sons, New York. 1984.
18. De Monte M, Nonnenmacher H, Brignon N, Ullmann M, Martin JP: A multivariate statistical analysis to follow the course of disease after infection of cats with different strains of the Feline Immunodeficiency Virus (F.I.V). J Virol Methods 2002; 103: 157-70.
19. Metha CR, Patel NR: StatXact, Statistical Software for exact Non Parametric Inference. CYTEL Software Corp., Cambridge (MA), USA. 1992.
20. Roberts DK, Thorne SE, Pearson C: The experience of dyspnea in late-stage cancer. Patients' and nurses' perspectives. Cancer Nurs 1993; 16: 310-20.
21. Webb M, Moody LE, Mason LA: Dyspnea assessment and management in hospice patients with pulmonary disorders. Am J Hosp Palliat Care 2000; 17: 259-64.
22. Jennings AL, Davies AN, Higgins JPT, Gibbs JSR, Broadley K: A systematic review of the use of opioids in the management of dyspnea. Thorax 2002; 57: 939-44.